Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.3.0.814
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Revenues:        
Product revenues $ 1,209,321 $ 588,343 $ 2,963,073 $ 2,456,171
Other service revenues 33,709 $ 44,861 93,663 84,623
Development service revenues 3,404 25,842 103,846
Total revenues 1,246,434 $ 633,204 3,082,578 2,644,640
Cost of product revenues 560,394 315,852 1,340,824 1,243,472
Research and development costs 480,280 873,366 1,434,723 2,589,410
Selling, general, and administrative expenses $ 2,132,777 $ 2,062,309 6,608,829 $ 5,792,241
Restructuring charges $ 1,252,584
Gain (loss) on change in fair value of derivative liabilities $ (4,338,601)
Operating loss $ (1,927,017) $ (2,618,323) $ (7,554,382) (2,641,882)
Other income (expense):        
Gain on change in fair value of derivative liabilities 1,950,329 (781,157) 981,222 578,179
Other income, net 45,302 38,237 243,505 167,614
Interest income 2,692 2,804 14,887 10,055
Interest expense (316,705) (288,783) (936,043) (723,886)
Net loss $ (245,399) $ (3,647,222) $ (7,250,811) $ (2,609,920)
Net loss per share attributable to common stockholders:        
Basic and diluted (in dollars per share) $ 0 $ (0) $ (0.10) $ (0.04)
Weighted average shares outstanding:        
Basic and diluted (in shares) 74,912,906 58,957,191 74,878,962 58,864,305